Key points from article :
Yuva Biosciences secured $7.5 million for its topical hair and skin treatment.
Using AI, the company discovered its lead compound (Y100) with the greatest potential to boost mitochondria levels.
Y100 targets mitochondrial dysfunction, a cellular issue linked to aging and hair loss.
Early trials of Y100 incorporated products have shown positive results.
They partnered with BosleyMD to launch its new “Revive Plus densifying foam” product to combat hairloss.
Yuva Bio believes their approach can be applied to other tissues and organs in the body.
“...potential to address other mitochondrial-related issues such as ovarian aging (fertility and menopausal issues), wound care and more,” said Greg Schmergel, CEO of Yuva Bio.
